Addiction epidemic sees Nigeria ban cough syrups containing codeine

Organisation: Position: Deadline Date: Location:

Nigeria has announced a ban on the production and import of cough syrup containing codeine after its investigation into its role in an addiction epidemic, reports BBC News. A health ministry spokesperson is quoted as saying that remaining stocks in shops could be sold with a prescription.

The report says the investigation showed the syrup being sold on the black market to be used by young Nigerians to get high. It recorded a number of pharmaceutical figures selling the drug illegally.

The joint probe prompted a swift response from people across the country, including Nigeria’s first lady, Aisha Buhari, who said in an Instagram post she was “deeply saddened” by the rise of the problem, especially in the north of Nigeria. “I call on all security agencies, lawmakers, judiciary, drug manufacturers, civil society, regulators, teachers, parents, neighbours and you to take this as a personal war and halt the menace,” she added.

However, Olajide Oshundun, the Ministry of Health’s assistant director of information, said the ban was a result of months of work by a committee, which recently submitted a report into the widespread abuse of the medication.

While existing stocks could be sold, manufacturers in Nigeria “have been told by federal government not to use codeine in cough syrup”, Oshundun is quoted in the report as saying. “Those that want to import the substance, it is been banned now. It is completely banned,” he added.

The cough syrup was legal, but it was against the law to sell it to people without a doctor’s prescription or those who did not have a pharmaceutical licence.

The Nigerian Senate estimates that as many as 3m bottles of codeine syrup are drunk every single day in just two states, Kano and Jigawa. The report says an undercover team caught one executive from Emzor Pharmaceuticals boasting he could sell “1m cartons” in a week on the black market. But Emzor said its representative only had access to a very limited amount of its brand of syrup, Emzolyn with codeine, and could not sell large quantities illegally.

According to the report, Emzor released a statement on Facebook emphasising its commitment to the proper “handling, production, storing and distribution of products containing codeine”. It has suspended all distribution pending a “full and thorough investigation” and has fired the employee involved.

“We hope the findings of the documentary will shed further light on the extent and impact of the illicit trade and consumption of codeine,” the statement said. “We hope that full stakeholder engagement will result in impactful action against the abuse, smuggling and faking of drugs on the continent.”

BBC News report

Receive Medical Brief's free weekly e-newsletter



Related Posts

Thank you for subscribing to MedicalBrief


MedicalBrief is Africa’s premier medical news and research weekly newsletter. MedicalBrief is published every Thursday and delivered free of charge by email to over 33 000 health professionals.

Please consider completing the form below. The information you supply is optional and will only be used to compile a demographic profile of our subscribers. Your personal details will never be shared with a third party.


Thank you for taking the time to complete the form.